Gen Prin Sp Class

GENERAL PRINCIPLES Zenaida N. Maglaya, MD; FPSECP Department of Pharmacology

GENERAL PRINCIPLES ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

PHARMACOKINETICS ,[object Object],[object Object],[object Object],[object Object]

FACTORS AFFECTING ABSORPTION ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

FACTORS AFFECTING ABSORPTION ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

DEGREE OF IONIZATION ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

FORMULA ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

EXAMPLE OF WEAK ACID WITH PKA OF 8 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

EXAMPLE OF A WEAK BASE WITH PKA OF 8 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

ROUTES OF ADMINISTRATION ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

DISTRIBUTION OF DRUGS ,[object Object],[object Object],[object Object],[object Object],[object Object]

METABOLISM OR BIOTRANSFORMATION OF DRUGS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

PHASE I METABOLISM ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

PHASE II METABOLISM ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

DRUG METABOLISM ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

DRUG METABOLISM ,[object Object],[object Object],[object Object],[object Object],[object Object]

EXCRETION ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

QUANTITATIVE PHARMACOKINETICS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

DOSAGE REGIMEN ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

DRUG EVALUATION ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Thank You! ,[object Object],[object Object],[object Object]

Gen Prin Sp Class

Recommended

Recommended

More Related Content

Viewers also liked

Viewers also liked (20)

Similar to Gen Prin Sp Class

Similar to Gen Prin Sp Class (20)

More from MD Specialclass

More from MD Specialclass (20)

Recently uploaded

Recently uploaded (20)

Gen Prin Sp Class